Page last updated: 2024-11-07

metaraminol and Uremia

metaraminol has been researched along with Uremia in 2 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BALDUS, WP1
FEICHTER, RN1
SUMMERSKILL, WH1
HUNT, JC1
WAKIM, KG1
Sugerman, HJ1
Berkowitz, HD1
Davidson, DT1
Miller, LD1

Other Studies

2 other studies available for metaraminol and Uremia

ArticleYear
THE KIDNEY IN CIRRHOSIS. II. DISORDERS OF RENAL FUNCTION.
    Annals of internal medicine, 1964, Volume: 60

    Topics: Aminophylline; Ascites; Blood Chemical Analysis; Creatine; Creatinine; Diuretics; Humans; Inulin; Ki

1964
Treatment of the hepatorenal syndrome with metaraminol.
    Surgical forum, 1970, Volume: 21

    Topics: Anuria; Arteries; Blood Pressure; Blood Urea Nitrogen; Central Venous Pressure; Creatinine; Humans;

1970